Acute Lymphoblastic Leukemia Treatment

Role of Nelarabine injection in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma

Cancer

Role of Nelarabine injection in the treatment of T-cell acute lymphoblastic leukemia/lymphoma

Role of Nelarabine injection in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic…

Indian Generic Medicines7 月 8, 2024

Disclaimer

Indian Generic Medicines (IGM) is a pharmaceutical trading entity that procures and supplies prescribed medicines strictly from manufacturers or duly authorized distributors. The company does not manufacture, formulate, or alter any pharmaceutical products.

All trademarks, brand names, and product names referenced remain the property of their respective owners. Any use of such names is solely for identification purposes and is in compliance with the provisions of the Trademark Act, 1999, including principles of fair use.

Indian Generic Medicines (IGM) Private Ltd does not claim ownership of, nor does it assert any rights over, any patents associated with the products supplied. Compliance with patent laws, including the Patents Act, 1970, rests with the respective patent holders, manufacturers, or marketing authorization holders.

The company facilitates access to certain medicines, including new launches, through legally permissible channels such as named patient import, strictly against valid prescriptions and in accordance with applicable laws and regulatory requirements.

Nothing herein shall be construed as an inducement or authorization to infringe any intellectual property rights.

Acute Lymphoblastic Leukemia

Role of Nelarabine injection in the treatment of T-cell acute lymphoblastic leukemia/lymphoma

Company

Contact Us

Enquire Now

Disclaimer